ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES EUROPEAN COOPERATION IN HEALTH TECHNOLOGY ASSESSMENT

Published Oct 31, 2016
Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, Austria.  The panel was moderated by Finn Børlum Kristensen, MD, PhD, Professor, University of Southern Denmark, Hilleroed, Denmark. Speakers for the discussion panel included:
  • Dominik Schnichels, Head of Unit, DG SANTE B4, Medical Products: Quality, Safety, Innovation, European Commission, Brussels, Belgium
  • Zoe Garrett, MRes, Senior Technical Adviser, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence, Manchester, UK
  • Rui Santos Ivo, Vice-President, Executive Board, National Authority of Medicines and Health Products, Lisbon, Portugal
  • Tomas Tesar, PharmD, PhD, MBA, Member, Reimbursement Committee, Union Health Insurance Fund, Bratislava, Slovakia
The panelists acknowledged that while decision making on patient access to health technologies will remain a sole national competence of the European Union (EU) Member States, they stressed that opportunities do exist to improve European cooperation on HTA. Through the work of EUnetHTA, European cooperation on HTA has resulted in methodological and process support tools that facilitate collaborative scientific work and production of HTA information that can be shared across borders. The speakers discussed a number of important issues that could contribute to a permanent solution for sustainable HTA cooperation in Europe, including: - identifying ways in which the collaborative work produced at the European level can fit into national HTA and decision-making processes - creating processes to ensure that European cooperation effectively and efficiently contributes to HTA in participating countries - exploring opportunities and plans that can support synergy between European and national HTA processes - developing strategies to support regional cooperation between Member States and the EU Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×